Welcome to the FDA

Lyrica (pregabalin) was also reviewed by the FDA as an adjunctive treatment for partial epileptic seizures in adults. In June 2005, the FDA granted approval to market Lyrica for adjunctive treatment of partial epileptic seizures in adults.

Browser Compatibility

This template has been tested in the following browsers:

  • Internet Explorer 8
  • FireFox 3
  • Google Chrome 13